Colgate Protects Against Tech Stock Decay, Street Finds
This article was originally published in The Tan Sheet
Executive Summary
Colgate-Palmolive's steady earnings growth and ability to shrug off the effects of a weak Euro made it a safe haven for investors in the second half of 2000.
You may also be interested in...
Consumer Products Firms To Benefit From Defensive Economy - Analyst
Predictions the economy will slow could benefit consumer products companies in 2001, as consumers turn from risky stock picks to defensive stocks, according to Goldman Sachs analyst Amy Low Chasen.
Colgate Three-Year Product Pipeline Includes 100+ Screened Items
Almost 60% of Colgate-Palmolive's 1999 U.S. sales came from products launched in the last five years, Colgate Executive Vice President & North America President Ian Cook reported at a Morgan Stanley Dean Witter conference in New York City Nov. 9.
PPA-Free Cough/Cold, Appetite Suppressant Formulations Planned
Novartis Consumer Health anticipates launching Tavist Allergy/Sinus/Headache caplets in time for the spring allergy season.